Vertex Pharmaceuticals(DE:VX1)
€487.20-6.90 (-1.40%)
DE:VX1
Vertex Pharmaceuticals earnings date
€487.20
At close:-6.90 (-1.40%)
Vertex Pharmaceuticals (VX1) Q1 2026 Earnings Report
23 Followers
DE:VX1 Q1 2026 EPS Results
- Actual EPS
- EUR 4.06
- Consensus EPS
- EUR 3.85
- Beat/Miss
- Beat by +EUR 0.21
- One Year Ago EPS
- EUR 3.68
DE:VX1 Q1 2026 Revenue Results
- Actual Revenue
- EUR 2.73B
- Expected Revenue
- EUR 2.72B
- Beat/Miss
- Beat by +EUR 16.51M
- YoY Revenue Growth
- +9.70%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/04/2026
- Time
- After Close
- Conference Call
- Monday, May 4, 2026
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:VX1 Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 3.81- | 4.56 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.374.32 | 4.35 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.304.29 | 4.1 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.854.06 | 3.68 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.644.56 | 3.61 | 26.38% (+0.95) | |
| Nov 03, 2025 | 2025 (Q3) | 4.154.35 | 3.97 | 9.59% (+0.38) | |
| Aug 06, 2025 | 2025 (Q2) | 3.894.10 | -11.64 | 135.23% (+15.74) | |
| May 05, 2025 | 2025 (Q1) | 3.923.68 | 4.32 | -14.71% (-0.64) | |
| Feb 10, 2025 | 2024 (Q4) | 3.643.61 | 3.81 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.703.97 | 3.7 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


